Fluorouracil (5-FU) for nonmelanoma skin cancer - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Fluorouracil (5-FU) for nonmelanoma skin cancer - [Medication] - Quest Diagnostics Patient Health Library Fluorouracil (5-FU) for nonmelanoma skin cancer - [Medication] - Quest Diagnostics Patient Health Library Cancer, Skin, hair, and nails, 5-...
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
Carac (FLUOROURACIL) Cream 20985 Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Carac (FLUOROURACIL) Cream Company:- Dermik Labs Application No.:- 020985 Approval Date:-10/27/2000 Approval Letter(s) - Printed Labeling - Part 1 - Part 2 - Medical Review(s) - Part 1 - Part 2 - Chemistry Review(s) - Pharmacology Review(s) - Part 1 - Part 2 - Statistical...
author: USERNAME
C:\Data\NDA\NDA 20985 Carac Cream 0.05%\S-004_AL_APLetter.doc page 1
author: Margo Owens
http://www.fda.gov/cder/ogd/rld/rld_labeling_approved_january_2001.html Jan 4 STROMECTOL letter label ivermectin tablets 50-742 S-005 Jan 5 EPIVIR letter label lamivudine tablets 20-564 S-011 lamivudine oral solution 20-596 S-012 EXELON letter label rivastigmine tartrate capsules 21-025 S-003 rivastigmine tartrate oral solution 20-823 S-003 STADOL letter label butorphanol tartrate nasal solution 19-890 S-015 Jan 10 FEMARA letter label letrozole tablets...
author: USERNAME
APPROVED LABELING NDA 20-985/S-0001 NDA 20- 985/ S- 001 Rx Only CaracO O Cream 0.5% (fluorouracil cream) FOR TOPICAL DERMATOLOGICAL USE ONLY (NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE) DESCRIPTION Carac (fluorouracil cream) Cream, 0.5%, contains fluorouracil for topical dermatologic useCarac and nine patients who received Efudex® 5% Cream had...
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 12
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 11
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 10
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 9
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 8
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 7
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 6
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 5
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 4
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 3
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 2
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
APPROVED LABELING NDA 20-985/S-0001 page 1
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
LABELING SUPPLEMENT APPROVAL LETTER NDA 20-985/S-001 page 2
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
LABELING SUPPLEMENT APPROVAL LETTER NDA 20-985/S-001 page 1
author: JFG
subject: CARAC CREAM (FLUOROURACIL CREAM)
Prescription and OTC Drug Product List 5/2001 Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 5: January-May 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE - ADD - ALMOTRIPTAN MALATE CAPSULE; ORAL - ADD - TABLET; ORAL ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE - ADD - AXERT - DLT - + MIKART 150MG;180MG...
FDA Drug Approvals List January 2001 - Drug Approvals for January 2001 Definitions and Notes Original New Drug Applications Original Application #: 021208 Approval Date: 12-JAN-01 Trade Name: REMERON SOLTAB Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET, ORALLY DISINTEGRATING Applicant: ORGANON INC Active Ingredient(s): MIRTAZAPINE OTC/RX Status: RX Indication(s): For the treatment of depression Original...
Dickman_A - Home -About IoZ -Research - Staff & Students -Postgraduate Study -Services -Publications -Seminars -Scientific Meetings -Jobs -Site Map -Contact Us - Search - Quick Links -Email Directory -PhD Posts -MSc Wild Animal -Health - MSc Wild Animal -Biology - Research Info - Research News - Research Projects -Software - Partner Sites -Zoological Society -of London (ZSL) -Centre for...
C:\Data\NDA\NDA 20985 Carac Cream 0.05%\S-004_AL_APLetter.doc page 3
author: Margo Owens
C:\Data\NDA\NDA 20985 Carac Cream 0.05%\S-004_AL_APLetter.doc page 2
author: Margo Owens
